Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Sulat currently holds 79,399 shares of Arch Therapeutics, Inc. (ARTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Sulat has been a net buyer of ARTH stock. They have purchased $369.2K and sold $0 worth of shares.
James R. Sulat's most recent insider trade was on Nov 14, 2023, when they sold 53,122 shares at $0.00 per share.
James R. Sulat serves as Executive at Arch Therapeutics, Inc. (ARTH). They have executed 42 insider transactions totaling $369.2K over their tenure at the company.
James R. Sulat holds the position of Executive at Arch Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James R. Sulat has shown a buying trading pattern, with $369.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James R. Sulat was on Sep 6, 2018, when they sold $199.7K worth of MNTA shares. This transaction involved 13,500 shares at $14.79 per share.
James R. Sulat currently owns 79,399 shares of Arch Therapeutics, Inc. (ARTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Sulat's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Sulat has 42 Form 4 filings on record as an insider at Arch Therapeutics, Inc..
Set alerts for James R. Sulat and 40,000+ other insiders.